Satisfaction with tolterodine: Assessing symptom-specific patient-reported goal achievement in the treatment of overactive bladder in female patients (STARGATE study)

International Journal of Clinical Practice

Volumn 62, Issue 2, 2008, Pages 191-196

  Choo, M S ^a   Doo, C K ^a   Lee, K S ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TOLTERODINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; NOCTURIA; OUTCOME ASSESSMENT; OVERACTIVE BLADDER; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE;

ADULT; AGED; BENZHYDRYL COMPOUNDS; CRESOLS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PATIENT SATISFACTION; PHENYLPROPANOLAMINE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE;

EID: 38149031825     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01652.x     Document Type: Article

References (21)

1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002 21 : 167 78.
2. Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001 87 : 760 6.
3. Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003 20 : 327 36.
4. Komaroff AL, Fagioli LR, Doolittle TH et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996 101 : 281 90.
5. Herbison P, Hay-Smith J, Ellis G et al. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003 326 : 841 4.
6. European Agency for the Evaluation of Medicinal Products and Committee for Proprietary Medicinal Products. Note for Guidance on the Clinical Investigation of Medicinal Products for the Treatment of Urinary Incontinence. London, UK, 2002.
7. Coyne KS, Matza LS, Kopp Z et al. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol 2006 49 : 1079 86.
8. The ERIQA Group. Assessing Treatment Impact Using Patient-Reported Outcomes (PROs): Challenges in Study Design, Conduct and Analysis, Meeting Report (Paris, 10-11 May 2004). Patient-reported Outcomes Newsl 2005 3 : 1 16.
9. Rodriguez LV, Blander DS, Dorey F et al. Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms. Urology 2003 62 : 49 53.
10. Abrams P, Kelleher CJ, Kerr LA et al. Overactive bladder significantly affects quality of life. Am J Manag Care 2000 6 : S580 90.
11. Brubaker L, Chapple C, Coyne KS et al. Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment. Urology 2006 68 : 3 8.
12. Kelleher CJ, Cardozo L, Chapple CR et al. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int 2005 95 : 81 5.
13. Kelleher CJ, Reese PR, Pleil AM et al. Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 2002 8 : S608 15.
14. Roberts R, Bavendam T, Glasser DB et al. Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial. Int J Clin Pract 2006 60 : 752 8.
15. Khullar V, Chapple C, Gabriel Z et al. The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis. Urology 2006 68 : 38 48.
16. Flood AB, Lorence DP, Ding J et al. The role of expectations in patients' reports of post-operative outcomes and improvement following therapy. Med Care 1993 31 : 1043 56.
17. Brubaker L, Shull B. EGGS for patient-centered outcomes. Int Urogynecol J Pelvic Floor Dysfunct 2005 16 : 171 3.
18. Likert R. Dissertation: a Technique for the Measurement of Attitudes. New York, NY : McGraw-Hill, 1932.
19. Donovan JL. Measuring the impact of nocturia on quality of life. BJU Int 1999 84 (Suppl. 1 21 5.
20. Liberman JN, Hunt TL, Stewart WF et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology 2001 57 : 1044 50.
21. Sofaer S, Firminger K. Patient perceptions of the quality of health services. Annu Rev Public Health 2005 26 : 513 59.